CBO's recent score tallied temporary PAMA delay as a cost rather than a savings, potentially making future delays less likely ...

With the approval, the company's automated clinical mass spec system, the Cobas I 601 analyzer, features an in vitro diagnostic menu of 39 tests.

The company intends to use the funding to advance its AI-powered microscopy system for infectious disease analysis.

The collaboration combines Guardant's diagnostics with Trial Library's AI-powered matching and patient navigation platform.

The digital immunoassay platform is designed to detect and quantify proteins at the single-molecule level in blood, serum, or plasma. The platform includes the Simoa HD-X Immunoassay Analyzer, which ...

The German startup is developing ultrasensitive lateral flow diagnostic tests that incorporate DNA origami signal amplification.

Uniogen's progress toward clinical commercialization aligns with larger internal goals of bringing cancer diagnostics to market, with a specific focus on women's health.

NEW YORK – What were the articles that gained the most interest from 360Dx readers last week? Here are the top five: ...

The test could potentially deliver noninvasive results in less than one minute through analysis of exhaled volatile organic compounds.

The test, which will use Iso-PAS technology, will be developed by Nipro of Japan in collaboration with other companies, institutes, and nonprofit organizations.